Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
(Ensifentrine + glycopyrrolate) by Verona Pharma for Chronic Obstructive Pulmonary Disease (COPD): Likelihood of Approval
(Ensifentrine + glycopyrrolate) is under clinical development by Verona Pharma and currently in Phase II for Chronic Obstructive Pulmonary Disease...
Ensifentrine by Verona Pharma for Bronchiectasis: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Bronchiectasis. According to GlobalData, Phase II...
Ensifentrine by Verona Pharma for Allergic Asthma: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Allergic Asthma. According to GlobalData, Phase...
Ensifentrine by Verona Pharma for Chronic Asthma: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Chronic Asthma. According to GlobalData, Phase...
Ensifentrine by Verona Pharma for Cystic Fibrosis: Likelihood of Approval
Ensifentrine is under clinical development by Verona Pharma and currently in Phase II for Cystic Fibrosis. According to GlobalData, Phase...